Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 7;26(1):16.
doi: 10.1007/s10544-024-00698-y.

SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer

Goknur Kara  1 , Bulent Ozpolat  2   3
Affiliations
Review

SPIONs: Superparamagnetic iron oxide-based nanoparticles for the delivery of microRNAi-therapeutics in cancer

Goknur Kara et al. Biomed Microdevices. .

Abstract

Non-coding RNA (ncRNA)-based therapeutics that induce RNA interference (RNAi), such as microRNAs (miRNAs), have drawn considerable attention as a novel class of targeted cancer therapeutics because of their capacity to specifically target oncogenes/protooncogenes that regulate key signaling pathways involved in carcinogenesis, tumor growth and progression, metastasis, cell survival, proliferation, angiogenesis, and drug resistance. However, clinical translation of miRNA-based therapeutics, in particular, has been challenging due to the ineffective delivery of ncRNA molecules into tumors and their uptake into cancer cells. Recently, superparamagnetic iron oxide-based nanoparticles (SPIONs) have emerged as highly effective and efficient for the delivery of therapeutic RNAs to malignant tissues, as well as theranostic (therapy and diagnostic) applications, due to their excellent biocompatibility, magnetic responsiveness, broad functional surface modification, safety, and biodistribution profiles. This review highlights recent advances in the use of SPIONs for the delivery of ncRNA-based therapeutics with an emphasis on their synthesis and coating strategies. Moreover, the advantages and current limitations of SPIONs and their future perspectives are discussed.

Keywords: RNAi; Superparamagnetic iron oxide nanoparticles; Targeted cancer therapy; miRNA.

PubMed Disclaimer

References

    1. M. Abu-Laban, R.R. Kumal, J. Casey, J. Becca, D. LaMaster, C.N. Pacheco, D.G. Sykes, L. Jensen, L.H. Haber, D.J. Hayes, Comparison of thermally actuated retro-diels-alder release groups for nanoparticle based nucleic acid delivery. J. Colloid Interface Sci. 526, 312–321 (2018) - PubMed - PMC - DOI
    1. D. Adams, A. Gonzalez-Duarte, W.D. O’Riordan, C.-C. Yang, M. Ueda, A.V. Kristen, I. Tournev, H.H. Schmidt, T. Coelho, J.L. Berk, Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379(1), 11–21 (2018) - PubMed - DOI
    1. T. Ahmad, H. Bae, I. Rhee, Y. Chang, J. Lee, S. Hong, Particle size dependence of relaxivity for silica-coated iron oxide nanoparticles. Curr. Appl. Phys. 12(3), 969–974 (2012) - DOI
    1. T. Ahmadzada, G. Reid, D.R. McKenzie, Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer. Biophys. Rev. 10, 69–86 (2018) - PubMed - PMC - DOI
    1. N. Ajinkya, X. Yu, P. Kaithal, H. Luo, P. Somani, S. Ramakrishna, Magnetic iron oxide nanoparticle (IONP) synthesis to applications: present and future. Materials 13(20), 4644 (2020) - PubMed - PMC - DOI

LinkOut - more resources